Centessa Pharmaceuticals (CNTA) shares were up more than 4% in recent Friday trading after Morgan Stanley upgraded the company's stock to overweight from equalweight and adjusted the price target to $26 from $11.
The company's trading volume stood at over 972,000 shares against a daily average of about 527,000.
Price: 16.54, Change: +0.69, Percent Change: +4.35
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。